Logo image of CRBD

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) Stock Fundamental Analysis

USA - NYSE:CRBD - US21871X2080

24.41 USD
-0.07 (-0.29%)
Last: 11/19/2025, 2:56:46 PM
Fundamental Rating

4

Overall CRBD gets a fundamental rating of 4 out of 10. We evaluated CRBD against 99 industry peers in the Financial Services industry. While CRBD is still in line with the averages on profitability rating, there are concerns on its financial health. CRBD has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CRBD had positive earnings in the past year.
CRBD had a positive operating cash flow in the past year.
CRBD had positive earnings in each of the past 5 years.
CRBD had a positive operating cash flow in each of the past 5 years.
CRBD Yearly Net Income VS EBIT VS OCF VS FCFCRBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

1.2 Ratios

CRBD has a worse Return On Assets (0.24%) than 66.67% of its industry peers.
CRBD has a Return On Equity (7.32%) which is in line with its industry peers.
Industry RankSector Rank
ROA 0.24%
ROE 7.32%
ROIC N/A
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)N/A
ROIC(5y)N/A
CRBD Yearly ROA, ROE, ROICCRBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

CRBD has a Profit Margin (5.64%) which is in line with its industry peers.
In the last couple of years the Profit Margin of CRBD has grown nicely.
CRBD's Operating Margin of 12.90% is in line compared to the rest of the industry. CRBD outperforms 48.48% of its industry peers.
CRBD's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.9%
PM (TTM) 5.64%
GM N/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
CRBD Yearly Profit, Operating, Gross MarginsCRBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

2

2. Health

2.1 Basic Checks

CRBD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CRBD has been reduced compared to 1 year ago.
The number of shares outstanding for CRBD has been reduced compared to 5 years ago.
Compared to 1 year ago, CRBD has a worse debt to assets ratio.
CRBD Yearly Shares OutstandingCRBD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200M 400M 600M
CRBD Yearly Total Debt VS Total AssetsCRBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

CRBD has a debt to FCF ratio of 6.80. This is a slightly negative value and a sign of low solvency as CRBD would need 6.80 years to pay back of all of its debts.
CRBD has a Debt to FCF ratio of 6.80. This is comparable to the rest of the industry: CRBD outperforms 59.60% of its industry peers.
CRBD has a Debt/Equity ratio of 0.81. This is a neutral value indicating CRBD is somewhat dependend on debt financing.
CRBD's Debt to Equity ratio of 0.81 is in line compared to the rest of the industry. CRBD outperforms 49.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 6.8
Altman-Z N/A
ROIC/WACCN/A
WACC6.23%
CRBD Yearly LT Debt VS Equity VS FCFCRBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CRBD Yearly Current Assets VS Current LiabilitesCRBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B 8B

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 1.29% over the past year.
CRBD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 115.54% yearly.
Looking at the last year, CRBD shows a very strong growth in Revenue. The Revenue has grown by 20.58%.
Measured over the past years, CRBD shows a quite strong growth in Revenue. The Revenue has been growing by 8.01% on average per year.
EPS 1Y (TTM)1.29%
EPS 3Y-31.14%
EPS 5Y115.54%
EPS Q2Q%-30.43%
Revenue 1Y (TTM)20.58%
Revenue growth 3Y-7.04%
Revenue growth 5Y8.01%
Sales Q2Q%24.11%

3.2 Future

The Earnings Per Share is expected to grow by 10.99% on average over the next years. This is quite good.
CRBD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.61% yearly.
EPS Next Y-2.56%
EPS Next 2Y7.69%
EPS Next 3Y11.02%
EPS Next 5Y10.99%
Revenue Next Year-10.4%
Revenue Next 2Y-2.8%
Revenue Next 3Y0.65%
Revenue Next 5Y2.61%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRBD Yearly Revenue VS EstimatesCRBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B 25B
CRBD Yearly EPS VS EstimatesCRBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

CRBD is valuated cheaply with a Price/Earnings ratio of 5.18.
Based on the Price/Earnings ratio, CRBD is valued cheaply inside the industry as 91.92% of the companies are valued more expensively.
CRBD is valuated cheaply when we compare the Price/Earnings ratio to 25.47, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 4.35 indicates a rather cheap valuation of CRBD.
CRBD's Price/Forward Earnings ratio is rather cheap when compared to the industry. CRBD is cheaper than 91.92% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.42, CRBD is valued rather cheaply.
Industry RankSector Rank
PE 5.18
Fwd PE 4.35
CRBD Price Earnings VS Forward Price EarningsCRBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

72.73% of the companies in the same industry are more expensive than CRBD, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CRBD is valued a bit cheaper than 76.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.12
EV/EBITDA 8.8
CRBD Per share dataCRBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.04
EPS Next 2Y7.69%
EPS Next 3Y11.02%

5

5. Dividend

5.1 Amount

CRBD has a Yearly Dividend Yield of 6.51%, which is a nice return.
Compared to an average industry Dividend Yield of 4.68, CRBD pays a better dividend. On top of this CRBD pays more dividend than 85.86% of the companies listed in the same industry.
CRBD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 6.51%

5.2 History

CRBD does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

CRBD pays out 52.57% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP52.57%
EPS Next 2Y7.69%
EPS Next 3Y11.02%
CRBD Yearly Income VS Free CF VS DividendCRBD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B
CRBD Dividend Payout.CRBD Dividend Payout, showing the Payout Ratio.CRBD Dividend Payout.PayoutRetained Earnings

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64

NYSE:CRBD (11/19/2025, 2:56:46 PM)

24.41

-0.07 (-0.29%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)02-10 2026-02-10/amc
Inst Owners86.58%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap13.14B
Revenue(TTM)17.58B
Net Income(TTM)991.00M
Analysts79.05
Price Target33.82 (38.55%)
Short Float %0.01%
Short Ratio1.03
Dividend
Industry RankSector Rank
Dividend Yield 6.51%
Yearly Dividend0.92
Dividend Growth(5Y)N/A
DP52.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.09%
Min EPS beat(2)-9.38%
Max EPS beat(2)15.55%
EPS beat(4)2
Avg EPS beat(4)1.6%
Min EPS beat(4)-9.38%
Max EPS beat(4)15.55%
EPS beat(8)6
Avg EPS beat(8)3.78%
EPS beat(12)9
Avg EPS beat(12)6.23%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.99%
Min Revenue beat(2)-11.42%
Max Revenue beat(2)9.43%
Revenue beat(4)1
Avg Revenue beat(4)-7.19%
Min Revenue beat(4)-14.87%
Max Revenue beat(4)9.43%
Revenue beat(8)2
Avg Revenue beat(8)-15.26%
Revenue beat(12)4
Avg Revenue beat(12)-10.8%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.81%
PT rev (3m)16.02%
EPS NQ rev (1m)-1.66%
EPS NQ rev (3m)-8.31%
EPS NY rev (1m)-6.01%
EPS NY rev (3m)-4.75%
Revenue NQ rev (1m)0.7%
Revenue NQ rev (3m)-5.21%
Revenue NY rev (1m)-3.14%
Revenue NY rev (3m)-7.61%
Valuation
Industry RankSector Rank
PE 5.18
Fwd PE 4.35
P/S 0.75
P/FCF 8.12
P/OCF 8.12
P/B 0.97
P/tB 0.97
EV/EBITDA 8.8
EPS(TTM)4.71
EY19.3%
EPS(NY)5.61
Fwd EY23%
FCF(TTM)3.01
FCFY12.32%
OCF(TTM)3.01
OCFY12.32%
SpS32.65
BVpS25.15
TBVpS25.15
PEG (NY)N/A
PEG (5Y)0.04
Graham Number51.62
Profitability
Industry RankSector Rank
ROA 0.24%
ROE 7.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 12.9%
PM (TTM) 5.64%
GM N/A
FCFM 9.21%
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.38%
ROCE(5y)1.27%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 6.8
Debt/EBITDA 4.06
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 3.58
Cash Conversion 59.72%
Profit Quality 163.37%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACC6.23%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)144.44%
Profit Quality(5y)197%
High Growth Momentum
Growth
EPS 1Y (TTM)1.29%
EPS 3Y-31.14%
EPS 5Y115.54%
EPS Q2Q%-30.43%
EPS Next Y-2.56%
EPS Next 2Y7.69%
EPS Next 3Y11.02%
EPS Next 5Y10.99%
Revenue 1Y (TTM)20.58%
Revenue growth 3Y-7.04%
Revenue growth 5Y8.01%
Sales Q2Q%24.11%
Revenue Next Year-10.4%
Revenue Next 2Y-2.8%
Revenue Next 3Y0.65%
Revenue Next 5Y2.61%
EBIT growth 1Y291.07%
EBIT growth 3Y-25.44%
EBIT growth 5Y34.3%
EBIT Next Year-5.93%
EBIT Next 3Y-0.33%
EBIT Next 5YN/A
FCF growth 1Y-47.72%
FCF growth 3Y-4.39%
FCF growth 5Y-2.53%
OCF growth 1Y-47.72%
OCF growth 3Y-4.39%
OCF growth 5Y-2.53%

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 / CRBD FAQ

Can you provide the ChartMill fundamental rating for COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64?

ChartMill assigns a fundamental rating of 4 / 10 to CRBD.


Can you provide the valuation status for COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64?

ChartMill assigns a valuation rating of 6 / 10 to COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD). This can be considered as Fairly Valued.


How profitable is COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) stock?

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for CRBD stock?

The Earnings per Share (EPS) of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) is expected to decline by -2.56% in the next year.


How sustainable is the dividend of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) stock?

The dividend rating of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) is 5 / 10 and the dividend payout ratio is 52.57%.